| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| IL-17F | Human IL-17F Protein, His Tag | Human | HEK293 | ![]() | MALSSDS-PAGE | $1370.00 250ug | ||
| IL-17F | HOT ILF-C5243 | Cynomolgus IL-17F Protein, His Tag, low endotoxin | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |
| IL-17F | HOTAvitag ILF-H82Q9 | Biotinylated Human IL-17F Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $415.00 25ug | |
| IL-17F | HOT ILF-H5244 | Human IL-17F Protein, His Tag, low endotoxin (Mass Spec & MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $200.00 20ug | |
| IL-17F | Avitag ILF-C82Q3 | Biotinylated Cynomolgus IL-17F Protein, His,Avitag™ (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| IL-17F | Human IL-17F (H161R) Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $165.00 20ug | ||
| IL-17F | Mouse IL-17F Protein, His Tag, low endotoxin | Mouse | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | ||
| IL-17F | Avitag ILF-M82Q3 | Biotinylated Mouse IL-17F Protein, His,Avitag™ (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Sonelokimab | ALX-0761; MSB-0010841; M-1095 | Phase 3 Clinical | Ablynx Nv | Arthritis, Psoriatic; Hidradenitis Suppurativa; Psoriasis | 상세 |
| DMT-310 | DMT-310 | Phase 3 Clinical | Dermata | Acne Vulgaris; Rosacea | 상세 |
| ORKA-002 | ORKA-002; PR-029; ORKA-021 | Phase 2 Clinical | Paragon Therapeutics Inc | Arthritis, Psoriatic; Plaque psoriasis; Psoriasis | 상세 |
| PN-881 | PN-881 | Phase 1 Clinical | Protagonist Therapeutics Inc | Dermatitis; Psoriasis | 상세 |
| HY-1770 | HY-1770; HT-17; HT17; YF02; HT25; GH02; HY1770 | Phase 1 Clinical | Suzhou Pharmavan Co Ltd | Dermatitis, Atopic; Plaque psoriasis | 상세 |